Cancer-Selective Targeting of the NF-?B Survival Pathway in Multiple Myeloma with the GADD45ß/MKK7 Inhibitor, DTP3 (2015)
Attributed to:
Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.v126.23.868.868
Publication URI: http://www.bloodjournal.org/content/126/23/868?sso-checked=true
Type: Journal Article/Review
Parent Publication: Blood
Issue: 23